Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MAP3K1
is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family of serine/threonine kinases.
MAP3K1
regulates JNK activation and is unique among human kinases in that it also encodes an E3 ligase domain that ubiquitylates c-Jun and ERK1/2. Full length
MAP3K1
regulates cell migration and contributes to pro-survival signaling while its
caspase 3
-mediated cleavage generates a C-terminal kinase domain that promotes apoptosis. The critical function of
MAP3K1
in cell fate decisions suggests that it may be a target for deregulation in cancer. Recent large-scale genomic studies have revealed that
MAP3K1
copy number loss and somatic missense or nonsense mutations are observed in a significant number of different cancers, being most prominent in luminal breast cancer. The alteration of
MAP3K1
in diverse cancer types demonstrates the importance of defining phenotypes for possible therapeutic targeting of tumor cell vulnerabilities created when
MAP3K1
function is lost or gained.
...
PMID:MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis. 2438 4
<< Previous
1
2
3